TP53 and small cell lung carcinoma: About 95% of SCLC patients have TP53 mutations [43]; therefore, as representative cell lines for our studies, we chose four SCLC cell lines containing common TP53 mutations and one SCLC cell line with wild-type TP53 (Supplementary Table 3).